Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent
responsible for the COVID-19 pandemic, has outspread at full tilt across the world. Although …

Modernizing inhaled medications through digital technology can help address persistent
problems of non-adherence and poor inhaler technique in patients with obstructive lung …

Background The albuterol Digihaler (albuterol 90 μg/dose) transmits data wirelessly to a
smart device application, which synchronizes with a Digital Health Platform to store and …

Post-COVID syndrome or long COVID is defined as the persistence of symptoms after
confirmed SARS-CoV-2 infection, the pathogen responsible for coronavirus disease. The …

Digital inhaler systems, remote patient monitoring, and remote therapeutic monitoring offer
great promise as diagnostic tools and therapeutic interventions to improve adherence and …

It has been shown that the better outcomes of chronic obstructive pulmonary disease
(COPD) are closely associated with adherence to drug therapy, independent of the …

Many inhaler devices with varying handling requirements for optimal use are available for
the treatment of asthma and chronic obstructive pulmonary disease (COPD). Patients may …

There are many different inhaler devices and medications on the market for the treatment of
asthma and chronic obstructive pulmonary disease, with over 230 drug-delivery system …

Wrong inhalation technique is associated to poor asthma clin... : Current Opinion in Pulmonary
Medicine Wrong inhalation technique is associated to poor asthma clinical outcomes. Is there …

Dry powder inhalers (DPIs) are drug–device combination products where the complexity of
the formulation, its interaction with the device, and input from users play important roles in …